NCT03581240
An Intermediate Expanded Use Trial of DFMO Not Available Not Available available NCT01505569
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors other Not Available completed NCT04868799
Finding New Targets by Proteomic Approaches (InnovRT1) No drug interventions Not Available Not Available completed NCT04987476
Rhabdoid Tumors Cellular Architecture by Single-cell Analyses (InnovRT-2) No drug interventions Not Available Not Available recruiting NCT03874455
Tazemetostat Expanded Access Program for Adults With Solid Tumors Not Available Not Available no_longer_available NCT02601950
A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma treatment 2 completed NCT05286801
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors treatment 1 / 2 recruiting NCT06465199
Difluoromethylornithine (DFMO) and AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas treatment 1 / 2 not_yet_recruiting NCT05407441
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors treatment 1 / 2 recruiting NCT01331135
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors treatment 1 completed NCT03500991
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors No drug interventions treatment 1 active_not_recruiting NCT03434262
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors treatment 1 completed NCT04897880
A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT treatment 2 terminated NCT03638167
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors No drug interventions treatment 1 active_not_recruiting NCT04521946
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer treatment 1 withdrawn NCT04185038
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors No drug interventions treatment 1 recruiting NCT05952687
Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors treatment 1 withdrawn NCT05835687
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors No drug interventions treatment 1 recruiting NCT05934630
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors No drug interventions Not Available Not Available active_not_recruiting NCT02114229
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors treatment 2 active_not_recruiting NCT02962167
Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT treatment 1 completed NCT04416568
Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers treatment 2 recruiting NCT06193759
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) No drug interventions treatment 1 recruiting